NFH New Frontier Health Corporation

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check One): ¨ Form 10-K  x Form 20-F  ¨ Form 11-K  ¨ Form 10-Q  ¨ Form 10-D  ¨ Form N-CEN  ¨  Form N-CSR

For Period Ended: December 31, 2020

For the Transition Period Ended: _____________________________________

PART I – REGISTRANT INFORMATION

New Frontier Health Corporation

Full Name of Registrant:

N/A

Former Name if Applicable:

10 Jiuxianqiao Road, Hengtong Business Park, B7 Building, 1/F

Address of Principal Executive Office (Street and number):

Chaoyang District, Beijing, China 100015

City, State and Zip Code

PART II – RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed (Check box if appropriate)

PART III – NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

New Frontier Health Corporation (the “Company”) was unable, without unreasonable effort or expense, to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2020 (the “Annual Report”) by April 30, 2021, the filing date applicable to foreign private issuers, due to a delay experienced by the Company in completing its financial statements and other related disclosures in the Annual Report in light of the April 12, 2021 statement (the “SEC Statement”) released by the Staff of the Securities and Exchange Commission relating to the accounting and reporting considerations for warrants issued by special purpose acquisition companies (“SPACs”) and former SPACs, like the Company. Specifically, the Company needs more time to incorporate the revised accounting treatment required by the SEC Statement for its warrants in its financial statements.

The Company anticipates that it will file the Annual Report no later than the fifteenth calendar day following the prescribed filing date.

PART IV – OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification:

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

x Yes  ¨ No

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

 ¨ Yes  x No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

New Frontier Health (NYSE:NFH)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024

New Frontier Health (NYSE:NFH)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024